Related references
Note: Only part of the references are listed.The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial
Shima Abdollahi et al.
BMJ OPEN (2019)
Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Hang Zhao et al.
OBESITY (2019)
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials
S. M. Mousavi et al.
OBESITY REVIEWS (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
ShadiSadat Seyyedebrahimi et al.
ACTA DIABETOLOGICA (2018)
The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
Ahmad Zare Javid et al.
PHYTOTHERAPY RESEARCH (2017)
Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus
Haruki Imamura et al.
INTERNATIONAL HEART JOURNAL (2017)
Resveratrol protects against oxidized low-density lipoprotein-induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial-derived oxidative stress
Yujie Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver
Caio Y. Yonamine et al.
MOLECULES (2017)
Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
Xiangyun Zhu et al.
NUTRITION & METABOLISM (2017)
Universal equation for estimating ideal body weight and body weight at any BMI
Courtney M. Peterson et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
Silvie Timmers et al.
DIABETES CARE (2016)
Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study
Nima Motamed et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Anti-obesity effects of resveratrol: comparison between animal models and humans
Alfredo Fernandez-Quintela et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2016)
The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials
Julia Christenson et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2016)
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
S. Bo et al.
PHARMACOLOGICAL RESEARCH (2016)
Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
P. K. Bagul et al.
CURRENT MOLECULAR MEDICINE (2015)
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R. Scott Turner et al.
NEUROLOGY (2015)
The 4′-Hydroxyl Group of Resveratrol Is Functionally Important for Direct Activation of PPARα
Yoshie Takizawa et al.
PLOS ONE (2015)
Effects of Resveratrol in Patients With Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
Kian Peng Goh et al.
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM (2014)
Antiobesity and Vasoprotective Effects of Resveratrol in ApoE-Deficient Mice
Seon-Min Jeon et al.
JOURNAL OF MEDICINAL FOOD (2014)
Meta-analysis of genome-wide association study of homeostasis model assessment β cell function and insulin resistance in an East Asian population and the European results
Kyung-Won Hong et al.
MOLECULAR GENETICS AND GENOMICS (2014)
Mechanism linking diabetes mellitus and obesity
Abdullah S. Al-Goblan et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Prevalence of Obesity in Patients With Type 2 Diabetes Mellitus in Yemen
Butheinah A. Al-Sharafi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2014)
Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
Silvie Timmers et al.
RESVERATROL AND HEALTH (2013)
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome
Simona D'Amore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine
Iryna Voloshyna et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Ali Movahed et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
AMPK, insulin resistance, and the metabolic syndrome
Neil B. Ruderman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet
Goiuri Alberdi et al.
NUTRITION (2013)
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Munehiro Kitada et al.
DIABETES & METABOLISM JOURNAL (2013)
The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters
Joana M. Planas et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins
Takuya Yashiro et al.
ATHEROSCLEROSIS (2012)
Effects of resveratrol on the amelioration of insulin resistance in KKAy mice
Sifan Chen et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Resveratrol Attenuates Obesity-Associated Peripheral and Central Inflammation and Improves Memory Deficit in Mice Fed a High-Fat Diet
Byeong Tak Jeon et al.
DIABETES (2012)
Cholesterol 27-Hydroxylase but Not Apolipoprotein apoE Contributes to A2A Adenosine Receptor Stimulated Reverse Cholesterol Transport
Taiese Crystal Bingham et al.
INFLAMMATION (2012)
Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats
Zhi Tan et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Jill P. Crandall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents
Wonyoung Kang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats
Kuan-Hsing Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice
Soyoung Kim et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics
Lynne M. Howells et al.
CANCER PREVENTION RESEARCH (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial β-oxidation
Lu-Lu Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
SIRT1 mRNA Expression May Be Associated With Energy Expenditure and Insulin Sensitivity
Jarno Rutanen et al.
DIABETES (2010)
Glycemic Control and Weight Reduction Without Causing Hypoglycemia: The Case for Continued Safe Aggressive Care of Patients With Type 2 Diabetes Mellitus and Avoidance of Therapeutic Inertia
Stanley S. Schwartz et al.
MAYO CLINIC PROCEEDINGS (2010)
RESVERATROL/SRT501 Sirtuin SIRT1 Activator Treatment of Type 2 Diabetes
P. J. Elliott et al.
DRUGS OF THE FUTURE (2009)
Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes
Katarzyna Szkudelska et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways
Jen-Ying Deng et al.
DIABETES (2008)
Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women
S. B. Pedersen et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Identification of obesity in patients with type 2 diabetes from Australian primary care
Merlin C. Thomas et al.
DIABETES CARE (2006)
Diabetic microvascular complications - can the presence of one predict the development of another?
Aniz Girach et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice
H Inoue et al.
NEUROSCIENCE LETTERS (2003)
Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies
JW Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Validation of a new self-report instrument for measuring physical activity
M Aadahl et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
Plant foods and herbal sources of resveratrol
J Burns et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
The plasma parameter log (TG/HDL-C) as an atherogenic index:: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL).
M Dobiásová et al.
CLINICAL BIOCHEMISTRY (2001)
Intentional weight loss and mortality among overweight individuals with diabetes
DF Williamson et al.
DIABETES CARE (2000)
Share Paper
